Reductive activation of nitroheterocyclic compounds
Author:
- 1 April 1997
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 28 (4) , 485-487
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: reductive metabolism and semiquantitative localisation in human ovarian cancer multicellular spheroids as measured by electron energy loss spectroscopic analysisBritish Journal of Cancer, 1995
- Bioreductive drugs for cancer therapy: The search for tumor specificityInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of actionJournal of Antimicrobial Chemotherapy, 1993
- Nitroimidazole drugs - action and resistance mechanisms II. Mechanisms of resistanceJournal of Antimicrobial Chemotherapy, 1993
- Redox, Radiation, and Reductive BioactivationRadiation Research, 1992
- A review of hypoxic cell radiosensitizationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991
- Radicals of Nitroimidazole Derivatives: pH Dependence of Rates of Formation and Decay Related to Acid-base EquilibriaInternational Journal of Radiation Biology, 1987
- Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancerBiochemical Pharmacology, 1986
- Reduction of nitroimidazoles in vitro and DNA damageBiochemical Pharmacology, 1986
- Structure-cytotoxicity relationships of nitroimidazoles in an in vitro systemInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982